Tiziana Life Sciences (TLSA) Total Non-Current Liabilities (2019 - 2025)

Tiziana Life Sciences has reported Total Non-Current Liabilities for 7 years, with the latest figure at $11.4 million in Q4 2025.

• On a quarterly basis, Total Non-Current Liabilities rose 56.03% year-over-year to $11.4 million in Q4 2025; TTM through Dec 2025 was $11.4 million, a 56.03% increase from a year earlier, with the FY2025 full-year figure at $11.4 million, up 56.03% from the prior year.
• Total Non-Current Liabilities was $11.4 million for Q4 2025 at Tiziana Life Sciences, up from $7.4 million in the prior quarter.
• The five-year high for Total Non-Current Liabilities was $11.4 million in Q4 2025, with the low at $4.1 million in Q2 2023.
• Average Total Non-Current Liabilities over 5 years is $7.5 million, with a median of $7.4 million recorded in 2024.
• The sharpest annual moves came in 2022 and 2024: Total Non-Current Liabilities slumped 41.97% in 2022, then jumped 121.06% in 2024.
• Over 5 years, Total Non-Current Liabilities stood at $7.5 million in 2021, then fell by 8.48% to $6.9 million in 2022, then decreased by 3.81% to $6.6 million in 2023, then increased by 10.58% to $7.3 million in 2024, then soared by 56.03% to $11.4 million in 2025.
• The last three Total Non-Current Liabilities figures came in at $11.4 million (Q4 2025), $7.4 million (Q2 2025), and $7.3 million (Q4 2024), per Business Quant data.